|
Clinical Research Detail |
|
Title Of Study |
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
|
|
Disease Condition |
Type 2 Diabetes
|
|
Phase of Trial |
Phase-3
|
Discipline |
Diabetology
|
|
Start date of Trial |
7/29/2010
|
Closing Date of Trial |
10/29/2011
|
|
|
If you are a doctor interested in clinical research then upload your profile. Click
here
|
If you are a hospital interested in clinical research then upload your profile. Click
here
|
If you are a patient interested to know more about this clinical trial mail us at:
[email protected]
|